|
COMMERCE BUSINESS DAILY ISSUE OF APRIL 26,2000 PSA#2587Department of Transportation, Transportation Administrative Service
Center (TASC), Acquisition Services, SVC-180, 400 7th Street SW, Room
5106, Washington, DC 20590 Q -- FORENSIC DRUG TESTING LABORATORY SERVICES SOL DTTS59-2000-R-00432
POC Deborah Rincon at 202-366-6689 E-MAIL: Deborah Rincon,
deborah.rincon@tasc.dot.gov. The Department of Transportation (DOT)
Transportation Administration Service Center (TASC) plans to release a
Request for Proposal (RFP) for Forensic Drug Testing Laboratory
Services. TASC and current TASC customer agencies present urine
specimens for drug testing from anywhere in the USA and, to a limited
extent, foreign locations. These include specimens that must be handled
under various regulatory requirements, such as the US Department of
Health and Human Services, DOT, and the Department of Defense
regulations and guidelines. TASC as a fee-for-service entity must
acquire a service that provides the best quality for DOT and non-DOT
customers. TASC defines that quality as follows: TASC requires the
capability of performing at least 30,000 screening tests a year.
However, testing levels (amounts of specimens) fluctuate from day to
day. The offeror must be capable of performing at least 200 screening
tests of specimens submitted under this contract (regardless of other
work) within any 24 hours. It is an accepted industry standard for
laboratories to report negative screen tests within 24 hours of receipt
by the laboratory unless there are unusual circumstances on a specimen.
This is a quality expectation of DOT and its customer agencies. Our
testing overwhelmingly involves operating safety-sensitive employees.
It is imperative that these services provide accurate results in the
minimum time possible. The reduction of potential threats to public
safety is a paramount goal of this program. The offeror must be capable
of performing 20 confirmation tests under this contract (regardless of
other work) within a 24-hour period. Actual amounts of specimens
received per day may fluctuate. The offeror must be capable of
performing tests for drugs listed in Schedules I and II of the
Controlled Substances Act according to specific cutoff value(s) for
drug test results to be considered positive. These are provided by TASC
based on the drug involved. This testing must include a screening test
and, if the screen is positive, a confirmation test. Methods used must
be forensically sound and defensible by the laboratory. The offeror
must be capable of performing tests for adulteration and substitution.
This is in addition to specific gravity, pH, and creatinine and
quantitative levels for positive tests on request. Daily laboratory
test results reports must be provided electronically to DOT/TASC or
customer agencies. The industry standard is to electronically transmit
screen negative results within 24 hours of receipt. Specific
information is required on all specimens. Other data and report
requirements would indicate that the offeror utilizes a state-of-the
art information management system. This system must interface with a
testing management system called Heidi, that is utilized by DOT and
some of DOT's customers. The contract will be awarded based on "best
value" to the government for a base period and four option years. The
estimated start of contract performance will be October 1, 2000. The
RFP will be a full and open competition. Release of the RFP is planned
for the middle of May, 2000. The RFP will be distributed
electronically via the Government's electronic posting Web site at
http://www.eps.gov (reference DTTS59-2000-R-00432). THE GOVERNMENT WILL
NOT DISTRIBUTE HARD COPIES OF THE RFP; DISTRIBUTION WILL ONLY BE DONE
VIA THE AFOREMENTIONED METHOD SO FIRMS SHOULD NOT RESPOND TO THIS
NOTICE BY REQUESTING TO BE PLACED ON A SOLICITATION MAILING LIST. The
RFP and related documents will be provided in Microsoft Word format.
The RFP will have instructions for providing questions and comments.
DOT anticipates that all subsequent solicitation documents (e.g.,
amendments to the RFP and responses to questions) will be disseminated
to offerors via the same method. Posted 04/22/00 (W-SN447745). (0113) Loren Data Corp. http://www.ld.com (SYN# 0056 20000426\Q-0003.SOL)
Q - Medical Services Index Page
|
|